The circulating IL‐35+ regulatory B cells are associated with thyroid associated opthalmopathy

Author:

Li Qian1ORCID,Yang Cuixia1ORCID,Liu Cheng2ORCID,Zhang Yuehui1ORCID,An Ningyu1ORCID,Ma Xiumei1ORCID,Zheng Yang1ORCID,Cui Xiaomin1ORCID,Li Qian1

Affiliation:

1. Department of Ophthalmology, People's Hospital of Ningxia Hui Autonomous Region The Third Affiliated Clinical College of Ningxia Medical University Yinchuan Ningxia Hui Autonomous Region China

2. Medical Science Research Institution of Ningxia Hui Autonomous Region Medical Sci‐Tech Research Center of Ningxia Medical University Yinchuan Ningxia Hui Autonomous Region China

Abstract

AbstractBackgroundThyroid‐associated ophthalmopathy (TAO) is the most common orbital disease in adults, potentially leading to disfigurement and visual impairment. However, the causes of TAO are not fully understood. IL‐35+B cells are a newly identified regulatory B cells (Bregs) in maintaining immune balance in various autoimmune diseases. Yet, the influence of IL‐35+Bregs in TAO remains unexplored.MethodsThis study enrolled 36 healthy individuals and 14 TAO patients. We isolated peripheral blood mononuclear cells and stimulated them with IL‐35 and CpG for 48 h. Flow cytometry was used to measure the percentages of IL‐35+Bregs.ResultsThe percentage of circulating IL‐35+Bregs was higher in TAO patients, and this increase correlated positively with disease activity. IL‐35 significantly increased the generation of IL‐35+Bregs in healthy individuals. However, B cells from TAO patients exhibited potential impairment in transitioning into IL‐35+Breg phenotype under IL‐35 stimulation.ConclusionsOur results suggest a potential role of IL‐35+Bregs in the development of TAO, opening new avenues for understanding disease mechanisms and developing therapeutic approaches.

Funder

National Natural Science Foundation of China

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3